Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

HIV/AIDS

  • your selections
Clear Search

Filter Results

date

Tags

  • results
OPINION: New HIV Infections More Expensive Than Providing Antiretroviral Drugs To Existing Patients

In light of study findings released last week showing the risk of HIV transmission can be reduced by 96 percent if HIV-positive patients begin combination antiretroviral therapy as soon as possible, a San Francisco Chronicle editorial asks, “The evidence is clearly starting to show that it’s much better to treat patients earlier, but from where will the money come?”

Scientists ‘Tinker’ With HIV Drug Chemistry Hoping To Reduce Costs

The Clinton Health Access Initiative, founded by former President Bill Clinton, with funding from the Bill & Melinda Gates Foundation and the U.K. government, has hired former pharmaceutical company scientists “to tinker with the chemistry used to synthesize a key [HIV] drug, tenofovir, reducing the cost of manufacturing,” the Wall Street Journal reports.

Early HIV Treatment Can Reduce Transmission Risk By 96%, Study Results Show

Results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday “[i]n what is being hailed as a breakthrough in HIV prevention,” the Los Angeles Times reports (Maugh, 5/13).

Recent Releases In Global Health

Lessons Learned About Global Health From 30 Years Of HIV/AIDS: In the CDC’s Emerging Infectious Diseases (.pdf) journal, Kevin De Cock of the CDC, Harold Jaffe of Emory University and James Curran of the Emory Center for AIDS Research reflect on the emergence of HIV/AIDS 30 years ago this June; the…